Extraction and chromatographic separation methods in pharmacokinetic studies of Stobadine® - An indole-related antioxidant and free-radical scavenger

Biomedical Chromatography

Volumn 14, Issue 3, 2000, Pages 188-201

  Soltes L ^a   Bezek, S ^a   Ujhazy E ^a   Bauer, V ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; FREE RADICALS; LIQUID CHROMATOGRAPHY;

BIOANALYTICAL ASSAYS; CHROMATOGRAPHIC DETERMINATION; CHROMATOGRAPHIC SEPARATIONS; COMPREHENSIVE INFORMATION; EXTRACTION/SEPARATION; FREE-RADICAL SCAVENGERS; HUMAN VOLUNTEERS; PHARMACOKINETIC STUDIES; RADIOMETRICS; SEPARATION METHODS;

PHARMACOKINETICS;

SCAVENGER; STOBADINE;

ARTICLE; BIOASSAY; CHROMATOGRAPHY; RADIOMETRY; SPECTROFLUOROMETRY;

ANIMALIA; CANIS FAMILIARIS;

EID: 0343619438     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0801(200005)14:3<188::AID-BMC974>3.0.CO;2-F     Document Type: Article

References (75)

1. Barkov, N. K. 1971. Pharmacological properties of carbidine (in Russian). Farmakologija i Toksikologija 34:647-650.
2. Barkov, N. K. and Kutcherova, N. F. 1972. On the relation between the chemical structure and pharmacological activity of the carboline derivatives (in Russian). Khimitcheskij i Farmaceutitcheskij Zhurnal 6(8):23-27.
3. Barkov, N. K. 1973. On the mode of carbidine action (in Russian). Farmakologija i Toksikologija 36:154-157.
4. Barkov, N. K. and Kutcherova, N. F. 1975. Further study of the links between the chemical structure and pharmacological activity of the carboline derivatives (in Russian). Khimitcheskij i Farmaceutitcheskij Zhurnal 9(4):6-10.
5. Bauer, V. and Štolc, S. 1993. Isolated cells and tissues as models for studies of drug mechanism of action. Plzeňský lékařský Sborník, 67:17-25.
6. Bauerová, K., Bezek, Š., Bohov, P., Ďurišová, M. and Kukan, M. 1995. Evaluation of relative bioavailability of two stobadine preparations in dogs. Therapeutic Drug Monitoring 17:423.
7. Bauerová, K., Bohov, P., Ďurišová, M. and Bezek, Š. 1999. Bioequivalence study: Contribution to the development of an oral application form of stobadine dipalmitate. Methods and Findings in Experimental and Clinical Pharmacology 21:499-503.
8. Beneš, L. and Štolc, S. 1989. Stobadine. Drugs of Future 14:135-137.
9. Beneš, L. and Pronayová, N. 1994. Free radical scavenger prodrugs-potentially potent brain penetrating agents. Pharmazie 49:69-70.
10. Bezáková, Ž., Blešová, M. and Bachratá, M. 1993. Stobadine dichloride-study of physical-chemical properties and stability (in Slovak). Farmaceutický Obzor 62:247-252.
11. 60Co opens the blood-brain barrier for drugs in rats. Experientia 46:1017-1020.
12. 2 blockers on histamine-induced contraction of guinea-pig airways in vitro. Respiration 57:104-108.
13. 3H-labelled stobadin in rat plasma for pharmacokinetic purposes. Pharmazie 45:437-438.
14. Bittererová, J. 1989. Stobadine pharmacokinetics under normal and pathologically changed conditions in rats (in Slovak). PhD Thesis. Pharmaceutical Faculty of the Comenius University. Bratislava.
15. Blanchard, J. 1981. Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid Chromatographic analysis. Journal of Chromatography 226:455-460.
16. Boháčik, L'. 1996. Effect of chemical permeation enhancers and of drug forms on transdermal permeation (in Slovak). PhD Thesis, Pharmaceutical Faculty of the Comenius University, Bratislava
17. Chemical Abstracts. 1994. Index Guide, American Chemical Society, Columbus, Ohio, U.S.A.
18. Dzúrik, R. and Fedelešová, V. 1987. Report on the clinical study of the preparation stobadine in volunteers: a single administration (in Slovak). In: Stobadine, a New Medicine with Antiarrhythmic, Protective and Antihypoxic Effect on Myocardium. Institute of Experimental Pharmacology, SAS, Bratislava, Slovak Republic, 2358-2369.
19. Franz, T. J. 1975. Percutaneous absorption. On the relevance of in vitro data. Journal of Investigative Dermatology 64:190-195.
20. Gibaldi, M. and Perrier, D. 1982. Pharmacokinetics. Marcel Dekker. Inc., New York and Basel.
21. Horáková, L'. and Štolc, S. 1998. Antioxidant and pharmacodynamic effects of pyridoindole stobadine. General Pharmacology 30:627-638.
22. Kállay, Z., Bittererová J., Brejcha, A., Faberová V., Bezek, Š. and Trnovec, T. 1990. Plasma concentration, tissue distribution and excretion of the prospective cardioprotective agent cis-(-)-2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1H-pyrido-[4,3-b]indole dihydrochloride in rats. Arzneimittel-Forschung/Drug Research 40:974-979.
23. Kállay, Z., Šoltés, L. and Trnovec, T. 1991. Pharmacokinetics of stobadin and of the sum of its metabolites in rats during repeated administration. Biopharmaceutics and Drug Disposition 12:201-205.
24. Koprda, V., Boháčik, L'., Bohov, P. and Hadgraft, J. 1995. Skin permeation of stobadine acyl derivatives. Abstracts of the 4th International Conference on Prediction of Percutaneous Penetration. Vol. 4a, La Grande Motte, France, C26.
25. Koprda, V., Boháčik, L'., Bohov, P. and Hadgraft, J. 1996. Skin permeation of stobadine acyl-derivatives. In: Prediction of Percutaneous Penetration, Vol. 4B (Brain, K. R., James, V. J., Walters, K. A., Eds.) STS Publishing Ltd., Cardiff. United Kingdom. 93-95.
26. Koprda, V., Mihalová, D. and Boháčik, L'. 1998. The effect of Azone on penetration of pyridoindole acyl-derivatives across 5-day rat skin. In: Perspectives in Percutaneous Penetration, Vol. 6A. (Brain. K. R. and Walters, K. A., Eds.) STS Publishing Ltd., Cardiff. United Kingdom, 29.
27. Krištofová, A., Ujházy, E., Bezek, Š., Balonová, T. and Nosál, R. 1991. Stobadine toxicity and transplacental movement. Archives of Toxicology, Suppl. 14:280-284.
28. Kukan, M., Bezek, Š., Trnovec, T., Gabauer, I. and Styk, J. 1994. On the absorption of drugs using chronic dog ileal loop method. Methods and Findings in Experimental and Clinical Pharmacology 16:437-442.
29. Marko, V. 1985. Spectrofluorometric analysis in biological fluids of the dihydrochloride of (-)-cis-2,8-dimethyl-2,3,4,4a,5,9b-hexahydro-I-H-pyrido[4,3b]indole (DH 1011), a prospective antiarrhythmic. Pharmazie 40:192.
30. Marko, V., Štefek, M. and Šoltés, L. 1985. Gas Chromatographic determination of pentacaine in rat serum. Journal of Chromatography 339:410-413.
31. Marko, V. 1988. Determination of stobadine, a novel cardioprotective drug, using capillary gas chromatography with nitrogen-phosphorus detection after its selective solid-phase extraction from serum. Journal of Chromatography 433:269-275.
32. Marko, V., Filip, J., Uhrín, D., Trnovec, T. and Beneš, L. 1989. Synthesis of tritium-labelled stobadine. a new cardioprotective agent. Journal of Labelled Compounds and Radiopharmaceuticals 27:35-43.
33. 18-silica. Discussion of possible interactions. Journal of Pharmaceutical and Biomedical Analysis 8:297-301.
34. Marko, V., Šoltés, L. and Radová, K. 1990b. Polar interactions in solid-phase extraction of basic drugs by octadecylsilanized silica. Journal of Chromatographic Science 28:403-406.
35. McDowall, R. D. 1989. Sample preparation for biomedical analysis. Journal of Chromatography 492:3-58.
36. Mehta, A. C. 1986. Sample pretreament in the trace determination of drugs in biological fluids. Talanta 33:67-73.
37. Morgan, D. J. 1997. Drug disposition in mother and foetus. Clinical and Experimental Pharmacology and Physiology 24:869-873.
38. Nagai, Y., Irie, A., Masuda, Y., Oka, M. and Uno, H. 1979. Synthesis of 2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]-indole derivatives and their central nervous system activities. Journal of Medicinal Chemistry 22:677-683.
39. Ondriaš, K., Mišík, V., Gergel', D. and Staško, A. 1989. Lipid peroxidation of phosphatidylcholine liposomes depressed by the calcium channel blockers nifedipine and verapamil and by the antiarrhythmic-antihypoxic drug slobadine. Biochimica et Biophysica Acta 1003:238-245.
40. Oravcová, J. 1991. Interactions of drugs and of their optical isomers with plasma proteins (in Slovak). Ph.D. Thesis, Institute of Experimental Pharmacology. SAS, Bratislava.
41. Orviský, E., Šoltés, L. and Stančíková, M. 1997. High-molecular-weight hyaluronan - a valuable tool in testing the antioxidative activity of amphiphilic drugs stobadine and vinpocetine. Journal of Pharmaceutical and Biomedical Analysis 16:419-424.
42. Peck, C. C., Beal, S. L., Sheiner, L. B. and Nichols, A. I. 1984. Extended least squares nonlinear regression: possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic data. Journal of Pharmacokinetics and Biopharmaceutics 12:545-558.
43. 3H-stobadine in biological material. Journal of Radioanalytical and Nuclear Chemistry. Art. 111:117-122.
44. 3H)stobadin. Journal of Radioanalytical and Nuclear Chemistry, Art. 134:433-436.
45. Ščasnár, V., Bezek, Š. and Trnovec, T. 1989b. Fluorimetric assay of stobadine in serum of dogs. Journal of Pharmaceutical and Biomedical Analysis 7:1207-1212.
46. Šoltés, L., Beneš, L. and Berek, D. 1983. Selective preseparation of pentacaine from biological material by SEP-PAK C18 cartridge. Methods and Findings in Experimental and Clinical Pharmacology 5:461-465.
47. Šoltés, L., Berek, D. and Štefek, M. 1984. Efficient and selective isolation of local anaesthetics from biological fluids using C18 silica gel. Journal of Chromatography 286:223-227.
48. 3H-stobadin by means of thin-layer chromatography. Pharmazie 42:863-864.
49. Šoltés, L. 1989. High-performance liquid Chromatographic determination of beta-adrenoceptor blocking agents in body fluids. Biomedical Chromatography 3:139-152.
50. Šoltés, L., Kállay, Z., Bezek, Š. and Fedelešová, V. 1991. A high-performance liquid Chromatographic method for the determination of stobadin pharmacokinetics in serum. Biopharmaceutics and Drug Disposition 12:29-35.
51. Šoltés, L. 1992a. Enhanced selectivity of the isolation of basic drugs from body fluids by means of extraction minicolumns and sophisticated elution schemes. Biomedical Chromatography 6:43-49.
52. Šoltés, L. 1992b. Prechromatographic preparation of biological samples by extraction in a liquid-solid sorbent system for determination of basic drugs (in Slovak). Chemické Listy (Chemical Letters) 86:299-301.
53. Šoltés, L. and Sébille, B. 1997. Effective one/two step purification of various materials by solid-phase extraction. Biomedical Chromatography 11:348-351.
54. Sotníková, R., Okruhlicová, L'. and Noskovič, P. 1998. Endothelial protective effect of stobadine on ischemia-reperfusion-induced injury. General Physiology and Biophysics 17:253-264.
55. Sotníková, R. and Šoltés, L. 1997. Meeting Report "Recent Advances in the Mechanism of Drug Action". ISSX Newsletter 17(3):5.
56. Sotníková, R. and Šoltés, L. 1998. Meeting Report "The International Symposium on Drug Action on Reactive Oxygen Species with Special Attention to Stobadine". ISSX Newsletter 18(1):5 and 8.
57. Staško, A., Ondriáš, K., Mišík, V., Szöcsová, H. and Gergel', D. 1990. Stobadine - a novel scavenger of free radicals. Chemické Zvesti (Chemical Papers) 44:493-500.
58. Steenken, S., Sundquist, A. R., Jovanovic, S. V., Crockett, R. and Sies, H. 1992. Antioxidant activity of the pyridoindole stobadine: Pulse radiolytic characterization of one-electro-oxidized stobadine and quenching of singlet molecular oxygen. Chemical Research in Toxicology 5:355-360.
59. Štefek, M., Beneš, L. and Kočiš, P. 1986. In vivo biotransformation of DH 1011 (in Slovak). Československá Fyziologie. 35:367.
60. Štefek, M. and Beneš, L. 1987. Gas chromatographic determination of stobadine, N-desmethylstobadine and stobadine N-oxide in rat liver microsomal incubations. Journal of Chromatography 415:163-169.
61. Štefek, M., Beneš, L., Jergelová, M., Ščasnár, V., Turi-Nagy, L. and Kočiš, P. 1987. Biotransformation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent, in rat liver microsomes. Xenobiotica 17:1067-1073.
62. Štefek, M. and Beneš, L. 1989. Hydrogen peroxide-dependent liver microsomal N-demethylation and N-oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent. Xenobiotica 19:627-634.
63. Štefek, M., Beneš, L. and Zelník, V. 1989. N-oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent: the role of flavin-containing monooxygenase. Xenobiotica 19:143-150.
64. Štefek, M. and Beneš, L. 1991. Pyridoindole stobadine is a potent scavenger of hydroxyl radicals. FEBS Letters 294:264-266.
65. Štefek, M. 1993. In vitro studies on the interaction of the pyridoindole antioxidant stobadine with rat liver microsomal P450. Xenobiotica 23:983-993.
66. Štolc, S., Bauer, V., Beneš, L. and Tichý, M. 1983. Medicine with antiarrhythmic and antihypoxic activity and its method of preparation. Czechoslovak Patent: 229067; cf. also Swiss Patent: 651754 (1985); Swedish Patent: 8204693-9; Belgian Patent: 894148 (1985); German Patent: P-3231088; Spanish Patent: 553017; Japanese Patent: 1514040.
67. Taylor, D. C. 1986. Sites and mechanism of intestinal drug absorption. Pharmacy International 7:179-183.
68. Trinus, F. P. 1976. Pharmacotherapeutical Handbook (in Russian). Zdorovija. Kijev, Second Edn. 27-28.
69. Ujházy, E., Faberová, V., Dubovicky, M., Zemánek, M., Dedík, L. and Durišová, M. 1994. Placental transfer of stobadine at different gestational stages in rabbits. Teratology 50:33A.
70. Ujházy, E., Faberová, V., Dubovický, M., Zemánek, M., Janšák, J., Dedík, L. and Ďurišová, M. 1995. Placental transfer of stobadine at different gestational stages in rabbits-approximation by pharmacokinetic model (in Slovak). Československá Fyziologie 44:15-17.
71. Ujházy, E., Dubovický, M., Bezek, Š., Šoltés, L., Žačiková, S. and Janšák, J. 1999a. Stobadine excretion into milk: Study in rats. Fundamental and Clinical Pharmacology 13:368.
72. Ujházy, E., Dubovický, M., Šoltés, L., Bezek, Š. and Zemánek, M. 1999b, Stobadine placental transfer and excretion in breast milk: Studies in rats. Biomarkers and Environment 3:8.
73. Ujházy, E., Dubovický, M., Šoltés, L., Faberová, V., Zemánek, M. and Gajdošík, A. 1999c. Placental transfer of stobadine in rabbits. Life Sciences 65:2011-2014.
74. Ujházy, E., Dubovický, M., Šoltés, L., Faberová, V., Zemánek, M. and Gajdošík, A. 1999d. Placental transfer of antioxidant stobadine at different gestational stages in rabbits. Archives of Toxicology; MS B-123/99.
75. Wiechers, J. W. and de Zeeuw, R. A. 1991. Prodrugs and penetration enhancement: Implications for dermal metabolism. In: Prediction of Percutaneous Penetration (Scott. R. C., Guy, R. H., Hadgraft, J., Boddé, H. E., Eds.). IBC Technical Services Ltd., London, Vol. 2:259-269.